Scientific World Model

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

Showing 1–30 of 30 pages matching "gene-therapy"

💊 AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery AlternativesKG

therapeutic · 15,567 words · 67 hyp24 ana25 exp

Viral Vector Delivery Investment Landscape for NeurodegenerationKG

investment · 3,314 words · 287 hyp42 ana56 exp

💊 aav-gene-therapy-neurodegenerationKG

therapeutic · 3,267 words · 299 hyp55 ana80 exp

💊 Section 106: Gene Therapy Vectors in CBS/PSPKG

therapeutic · 3,119 words · 67 hyp25 ana20 exp

⚙️ AAV Gene Therapy Vectors for NeurodegenerationKG

mechanism · 2,941 words · 303 hyp61 ana77 exp

💊 Tau Gene TherapyKG

therapeutic · 2,650 words · 60 hyp22 ana8 exp

Gene Therapy for NeurodegenerationKG

investment · 2,321 words · 311 hyp57 ana62 exp

💊 Parkin (PRKN) Gene TherapyKG

therapeutic · 2,109 words · 60 hyp25 ana6 exp

💊 Section 113: Emerging Gene Therapy Approaches for CBS/PSPKG

therapeutic · 2,048 words · 67 hyp26 ana20 exp

🧪 AB-1005 (REGENERATE-PD) GDNF Gene Therapy TrialKG

clinical · 1,834 words · 26 hyp17 ana1 exp

💊 Section 241: Advanced Gene Therapy and CRISPR Approaches in CBS/PSPKG

therapeutic · 1,782 words · 69 hyp30 ana20 exp

💊 gba-gene-therapyKG

therapeutic · 1,690 words · 62 hyp24 ana18 exp

💊 Neurotrophic Factor Gene Therapy Programs — GDNF, CDNF, BDNF, NeurturinKG

therapeutic · 1,535 words · 59 hyp22 ana18 exp

💊 Gene Therapy for Neurodegenerative DiseasesKG

therapeutic · 1,490 words · 206 hyp62 ana16 exp

💊 AAV Gene Therapy Vectors for Neurodegenerative DiseasesKG

therapeutic · 1,465 words · 60 hyp43 ana25 exp

🏢 AD Gene Therapy and Genome Editing CompaniesKG

company · 1,385 words · 40 hyp19 ana1 exp

💊 GBA Gene Therapy for Parkinson's DiseaseKG

therapeutic · 1,237 words · 59 hyp35 ana75 exp

🧪 AB-1005 (REGENERATE-PD) GDNF Gene Therapy TrialKG

clinical · 1,167 words · 31 hyp17 ana14 exp

💊 Gene Therapy for Neurodegenerative DiseasesKG

therapeutic · 1,129 words · 170 hyp60 ana19 exp

💊 Etalanetug (E2814)KG

therapeutic · 1,124 words · 46 hyp23 ana3 exp

🧫 Gene Therapy: AAV Serotype Comparison for LRRK2 KnockdownKG

experiment · 989 words · 21 hyp20 ana9 exp

🧫 AAV Serotype Comparison for LRRK2 Knockdown in PD Gene TherapyKG

experiment · 969 words · 21 hyp20 ana22 exp

💊 AADC Gene Therapy for Parkinson's DiseaseKG

therapeutic · 968 words · 63 hyp31 ana60 exp

💊 AAV Vectors in Neurodegenerative Disease Gene TherapyKG

therapeutic · 911 words · 71 hyp43 ana27 exp

🔧 Gene Therapy for Neurodegenerative DiseasesKG

technology · 855 words · 134 hyp60 ana12 exp

AAV Gene Therapy for Neurodegeneration — Investment LandscapeKG

investment · 774 words · 285 hyp45 ana75 exp

AD/PD 2026 Gene TherapyKG

event · 708 words · 30 hyp17 ana1 exp

Gene Therapy for NeurodegenerationKG

investment · 679 words · 309 hyp59 ana60 exp

💊 CRISPR/Cas9 Gene Therapy for NeurodegenerationKG

therapeutic · 673 words · 299 hyp57 ana93 exp

AAIC 2026: Gene Therapy DevelopmentsKG

event · 519 words · 30 hyp17 ana1 exp